Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Dicerna Pharmaceuticals Inc (NASDAQ:DRNA)

5.92
Delayed Data
As of Feb 05
 -0.40 / -6.33%
Today’s Change
5.81
Today|||52-Week Range
27.33
-50.13%
Year-to-Date
No recent news for Dicerna Pharmaceuticals Inc.

Today’s Trading

Previous close6.32
Today’s open6.27
Day’s range5.81 - 6.27
Volume132,426
Average volume (3 months)130,935
Market cap$121.9M
Dividend yield--
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)+99.58%
Earnings growth (this year)-42.95%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.07

Competitors

 Today’s
change
Today’s
% change
PTXPernix Therapeutics ...-0.09-4.33%
PRQRProQR Therapeutics N...-0.23-4.20%
DRRXDURECT Corp-0.07-6.36%
MNOVMediciNova Inc-0.14-3.26%
Data as of 4:00pm ET, 02/05/2016

Financials

Next reporting dateMarch 24, 2016
EPS forecast (this quarter)-$0.84
Annual revenue (last year)$0.00
Annual profit (last year)-$47.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Douglas M. Fambrough
Senior VP-Operations &
Product Strategy
Theodore T. Ashburn
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers